Per Malmström
81 – 90 of 159
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2008
-
Mark
Exploring the two-gene ratio in breast cancer-independent roles for HOXB13 and IL17BR in prediction of clinical outcome
- Contribution to journal › Article
-
Mark
Vascular endothelial growth factor is a strong predictor of early distant recurrences in a prospective study of premenopausal women with lymph-node negative breast cancer
- Contribution to journal › Article
-
Mark
Gene expression profiling in primary breast cancer distinguishes patients developing local recurrence after breast conservation surgery with or without postoperative radiotherapy
- Contribution to journal › Article
-
Mark
A randomized feasibility/phase II study (SBG 2004-1) with dose-dense/tailored epirubicin, cyclophoshamide (EC) followed by docetaxel (T) or fixed dosed dose-dense EC/T versus T, doxorubicin and C (TAC) in node-positive breast cancer
(2008) EBCC-6, European Breast Cancer Conference, 2008 In European Journal of Cancer Supplements 6(7). p.116-117
- Contribution to journal › Published meeting abstract
-
Mark
Tiling array-CGH for the assessment of genomic similarities among synchronous unilateral and bilateral invasive breast cancer tumor pairs.
- Contribution to journal › Article
-
Mark
Establishment and implementation of common guidelines for 3D treatment planning for breast cancer in southern and western Sweden
- Contribution to journal › Published meeting abstract
-
Mark
SORENESS AND SENSITIVITY TO SUN EXPOSURE 10 TO 16 YEARS AFTER BREAST CANCER RADIOTHERAPY
- Contribution to journal › Published meeting abstract
-
Mark
Multizentrische Studien zur Postoperativen Strahlentherapie Niedriggradiger Astrozytome und Oligodendrogliome
- Contribution to journal › Article
- 2007
-
Mark
Radiotherapy and tamoxifen after mastectomy in postmenopausal women - 20 year follow-up of the South Sweden Breast Cancer group randomised trial SSBCG II : I
- Contribution to journal › Article
-
Mark
Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity
- Contribution to journal › Article
